Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
RetroNectin active Killer cells
TAS-102 (trifluridine and tipiracil, Lonsurf®)
Locations
1
China
The First＆Fifth Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Start Date
July 1, 2025
Primary Completion Date
December 31, 2027
Completion Date
June 30, 2028
Last Updated
October 8, 2025
NCT07528066
NCT07447050
NCT05689463
NCT07371663
NCT06488950
NCT05098197
Lead Sponsor
Chinese PLA General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions